7 clinical trials found.
-
A Phase 2 Study of BIO 300 in Patients with COVID-19
COVID-19 is caused by a virus that triggers inflammation of the lungs. This inflammation may damage the lungs and lead to scarring. This scarring causes ...Phase
Interventional
TRIAL ROLE: Principal Investigator
-
Registry of COVID-19 Survivors: Assessment of ICU and Non-ICU Survivors: A Creation of a COVID Survivorship Database
The purpose of this research study is to obtain a better understanding of the structure and functioning of the heart and lungs in those who ...Phase N/A Interventional
TRIAL ROLE: Principal Investigator
-
Enhancing Clinical Outcomes in Patients with Nontuberculous Mycobacteria: A Longitudinal Study
The purpose of this study is to observe what happens to patients with non-tuberculous mycobacteria (NTM). NTM are bacteria that may cause infection in the ...Phase N/A Interventional
TRIAL ROLE: Sub Investigator
-
Exhaled and nasal nitric oxide in children and adults with chronic wet cough
The purpose of this study is to see if we can use non-invasive tests called forced exhaled nitric oxide (FeNO) (a reading that we get ...Phase N/A
Observational
TRIAL ROLE: Sub Investigator
-
ARISE -A Randomized Double-Blind Placebo-Controlled Active Comparator Multicenter Study to Validate Patient-Reported Outcome Instruments in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium a
The purpose of this study is to validate a patient-reported outcomes questionnaire in newly diagnosed patients given amikacin liposome inhalation suspension (ALIS) as part of ...Phase
Interventional
TRIAL ROLE: Sub Investigator
-
An INS1007 Phase III program in Non Cystic Fibrosis Bronchiectasis
The purpose of this study is to evaluate the efficacy, safety, and tolerability of brensocatib as treatment for non-cystic fibrosis bronchiectasis (NCFBE). Brensocatib is an ...Phase
Interventional
TRIAL ROLE: Co-Investigator
-
ENCORE - A Randomized Double-Blind Placebo-Controlled Active Comparator Multicenter Study to Evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC)
The purpose of this study is to evaluate the effect and safety of amikacin liposome inhalation suspension (ALIS) treatment on patient-reported symptoms in patients newly ...Phase
Interventional
TRIAL ROLE: Sub Investigator
